Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. surgical removal
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Surgical Removal Articles & Analysis

43 news found

Everything You Need to Know about Capturing Full Arch Impressions and Designing / Fabricaing All on X Restorations

Everything You Need to Know about Capturing Full Arch Impressions and Designing / Fabricaing All on X Restorations

In this article we detail everything you need to capture to design and all on x type of restoration so you can quickly print a prosthesis and deliver it to your patient as quickly after surgery as possible. We think it is best to start with the end in mind and work backwards to the models you need to ...

ByCAD-Ray


AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary ...

ByAngioDynamics, Inc.


Revacept protects during carotid artery surgery

Revacept protects during carotid artery surgery

All patients required therapy because of dangerous narrowing of the carotid artery and received the nowadays standard basic therapy with the blood platelet inhibitors acetylsalicylic acid (Aspirin©) and/or clopidogrel to prevent renewed vascular occlusion (thrombosis). The vasoconstrictions were removed surgically or by inserting stents, or they were treated ...

ByadvanceCOR GmbH


BIOMARK’s GLIOBLASTOMA Study Published in CANCERS Demonstrates Inhibiting SAT1 sensitized cancer cells towards radiation and chemotherapy

BIOMARK’s GLIOBLASTOMA Study Published in CANCERS Demonstrates Inhibiting SAT1 sensitized cancer cells towards radiation and chemotherapy

The current treatment for GB involves surgical removal of the tumor followed by chemotherapy and radiation therapy. ...

ByBioMark Diagnostics Inc.


I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...

ByProUroCare Medical Inc.


University Hospital Tübingen carries out first Dexter surgeries in Germany

University Hospital Tübingen carries out first Dexter surgeries in Germany

Bernhard Krämer and their teams used Dexter in several surgical procedures including the removal of an ovarian cyst (cyst extirpation), the removal of an ovarian tumor (adnexectomy) and the removal of a patient’s uterus (hysterectomy). ...

ByDistalmotion SA


Neurona Therapeutics Awarded $8 Million by California Institute for Regenerative Medicine (CIRM) to Support Phase 1/2 Clinical Trial of NRTX-1001 for Chronic Focal Epilepsy

Neurona Therapeutics Awarded $8 Million by California Institute for Regenerative Medicine (CIRM) to Support Phase 1/2 Clinical Trial of NRTX-1001 for Chronic Focal Epilepsy

“About a third of individuals with epilepsy have drug-resistant seizures. Removal or ablation of the affected temporal lobe can be an option, but many people with epilepsy are not eligible or interested in a tissue-destructive procedure. ...

ByNeurona Therapeutics


Biostage Announces $5.1 Million Financing to Advance Clinical Trial

Biostage Announces $5.1 Million Financing to Advance Clinical Trial

Similar to how the BEI could be used to regenerate the esophagus, the Biostage Bronchial Implant would be used to regenerate a bronchus that has been surgically removed to treat bronchial cancer, injury or birth defects. ...

ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc.


Icecure medical presents Ice3 breast cancer trial interim data, hosts cryoablation symposium & conducts hands-on Prosense Training Sessions at the European Conference on Interventional Oncology

Icecure medical presents Ice3 breast cancer trial interim data, hosts cryoablation symposium & conducts hands-on Prosense Training Sessions at the European Conference on Interventional Oncology

(NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it hosted three key ProSense System events at the European Conference on Interventional Oncology (ECIO) from ...

ByIceCure Medical Ltd


Biostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the Bronchus

Biostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the Bronchus

Using a cell-seeded scaffold, which we call the Biostage Bronchial Implant, or BBI, we have performed the regeneration and repair of a bronchus (the airway that connects the trachea to the lungs) that was surgically removed from a pig. The bronchus regenerated, much as in the esophagus, first forming a tube and later developing into a bronchus with a functional ...

ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc.


SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath

SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath

“Treatment of rectal cancer most often involves radiation and chemotherapy followed by surgical removal of the rectum. Because the risk of non-healing of the bowel anastomosis is high, and the consequences could be dire, the surgeon temporarily diverts the stool from the anastomosis by creating an ostomy. ...

BySafeHeal


Neurona Therapeutics Presents Preclinical Data at the American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001, Being Evaluated in a Phase 1/2 Clinical Trial for Chronic Focal Epilepsy

Neurona Therapeutics Presents Preclinical Data at the American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001, Being Evaluated in a Phase 1/2 Clinical Trial for Chronic Focal Epilepsy

For some people with seizures that are resistant to drugs, epilepsy surgery, where the damaged temporal lobe is surgically removed or ablated by laser, can be an option. However, the current surgical options are not available or effective for all, are tissue-destructive, and can have significant adverse effects. ...

ByNeurona Therapeutics


GammaTile Therapy Delivers Targeted Radiation to Cancer Cells

GammaTile Therapy Delivers Targeted Radiation to Cancer Cells

The current standard of care for patients with operable malignant glioma tumors is surgical removal of the tumor followed by radiation and chemotherapy. ...

ByGT Medical Technologies, Inc.


Icecure Medical Receives Notice of Intention to Grant a European Patent Covering its Cryogenic Pump

Icecure Medical Receives Notice of Intention to Grant a European Patent Covering its Cryogenic Pump

(NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it received notification from the European Patent Office (the “EPO”) of an intention to ...

ByIceCure Medical Ltd


Axogen sponsors 2022 Donate Life Rose Parade® Float to help raise awareness of organ and tissue donation

Axogen sponsors 2022 Donate Life Rose Parade® Float to help raise awareness of organ and tissue donation

(NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced today that nerve repair patient Christopher (Chris) Brown has been selected to ride on the 2022 Donate Life Rose Parade Float. ...

ByAxogen (AXGN)


Icecure medical ltd. Closes $17 million underwritten public offering and partial exercise of over-allotment option

Icecure medical ltd. Closes $17 million underwritten public offering and partial exercise of over-allotment option

(NASDAQ: ICCM) (TASE: ICCM.TA) (the “Company” or “IceCure”), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the closing of its underwritten public offering of 3,892,152 shares of the Company’s ordinary ...

ByIceCure Medical Ltd


Neurona Therapeutics Announces C-Suite Leadership Team

Neurona Therapeutics Announces C-Suite Leadership Team

For people with seizures resistant to drugs, epilepsy surgery - where the damaged temporal lobe is surgically removed or ablated by laser - can be an option for some. However, the current surgical options are not available or effective for all, are tissue-destructive, and can have significant adverse effects. ...

ByNeurona Therapeutics


Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society

Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society

For people with seizures resistant to drugs, epilepsy surgery - where the damaged temporal lobe is surgically removed or ablated by laser - can be an option for some. However, the current surgical options are not available or effective for all, are tissue-destructive, and can have significant adverse effects. ...

ByNeurona Therapeutics


Icecure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources

Icecure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources

(NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the appointment of Mrs. Merav Nir Dotan to the new position of Vice President, Human Resources. ...

ByIceCure Medical Ltd


Lixte Biotechnology Holdings, Inc. Announces that enrollment has resumed in national cancer institute’s trial to determine ability of Lixte compound lb-100 to enter recurrent, malignant brain tumors

Lixte Biotechnology Holdings, Inc. Announces that enrollment has resumed in national cancer institute’s trial to determine ability of Lixte compound lb-100 to enter recurrent, malignant brain tumors

(Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. After enrolling two patients in the study, ...

ByLIXTE Biotechnology Holdings, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT